Pharmacology - First Aid Flashcards

1
Q

Enzyme Kinetics:

Michaelis-Menten Kinetics

A
  • Km is inversely related to the affinity of the enzyme for its substrate.
  • Vmax is directly proportional to the enzyme concentration.
  • Most enzymatic reactions follow a hyperbolic curve (ie, Michaelis-Menten kinetics); however, enzymatic reactions that exhibit a sigmoid curve usually indicate cooperative kinetics (eg, hemoglobin).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Enzyme Kinetics:

Lineweaver-Burk Plot

A
  • ↑ y-intercept, ↓ Vmax
  • The further to the right the x-intercept (ie. closer to zero), the greater the Km and the lower the affinity.
  • Competitive inhibitors cross each other, whereas noncompetitive inhibitors do not.
  • Kompetitive inhibitors increase Km.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Inhibitors

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Inhibitors:

  • resembles substrate
  • overcome by ↑ [S]
  • binda active site
  • no effect on Vmax
  • ↑ Km
  • ↓ potency
A

Reversible Competitive Inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Inhibitors:

  • resembles substrate
  • not overcome by ↑ [S]
  • binds active site
  • ↓ Vmax
  • no effect on Km
  • ↓ efficacy
A

Irreversible Competitive Inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Inhibitors:

  • does not resemble substrate
  • not overcome by ↑ [S]
  • does not bind active site
  • ↓ Vmax
  • no effect on Km
  • ↓ efficacy
A

Noncompetitive Inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pharmacokinetics:

fraction of administered drug reaching systemi circulation unchanged

A

Bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bioavailability of IV Dose

A

F = 100%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Bioavailability of Oral Dose

A

F typically < 100% due to incomplete absorption and first-pass metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pharmacokinetics:

theoretical volume occupied by the total amount of drug in the body relative to its plasma concentration

A

Volume of Distribution (Vd)

  • Apparent Vd of plasma protein–bound drugs can be altered by liver and kidney disease (↓ protein binding, ↑ Vd).
  • Drugs may distribute in more than one compartment.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pharmacokinetics:

  • the volume of plasma cleared of drug per unit time
  • may be impaired with defects in cardiac, hepatic, or renal function
A

Clearance (CL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pharmacokinetics:

the time required to change the amount of drug in the body by 1⁄2 during elimination

A

Half-Life (t1/2)

  • In first-order kinetics, a drug infused at a constant rate takes 4–5 half-lives to reach steady state.
  • It takes 3.3 half-lives to reach 90% of the steady-state level.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Dosage Calculations

A
  • In renal or liver disease, maintenance dose ↓ and loading dose is usually unchanged.
  • Time to steady state depends primarily on t1/2 and is independent of dose and dosing frequency.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Types of Drug Interactions:

  • effect of substance A and B together is equal to the sum of their individual effects
  • Aspirin
  • Acetaminophen
A

Additive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Types of Drug Interactions:

  • presence of substance A is required for the full effects of substance B
  • Cortisol on catecholamine responsiveness
A

Permissive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Types of Drug Interactions:

  • effect of substance A and B together is greater than the sum of their individual effects
  • Clopidogrel with Aspirin
A

Synergistic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Types of Drug Interactions:

  • acute decrease in response to a drug after initial/repeated administration
  • Nitrates
  • Niacin
  • Phenylephrine
  • LSD
  • MDMA
A

Tachyphylactic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Receptor Binding

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Receptor Binding:

  • shifts curve right (↓ potency), no change in efficacy
  • can be overcome by ↑ the concentration of agonist substrate
  • Diazepam (agonist) + Flumazenil (antagonist) on GABA receptor
A

Competitive Antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Receptor Binding:

  • shifts curve down (↓ efficacy)
  • cannot be overcome by ↑ agonist substrate concentration
  • Norepinephrine (agonist) + Phenoxybenzamine (antagonist) on α-receptors
A

Noncompetitive Antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Receptor Binding:

  • acts at same site as full agonist, but with lower maximal effect (↓ efficacy)
  • potency is an independent variable
  • Morphine (full agonist) vs. Buprenorphine (_____ agonist) at opioid μ-receptors
A

Partial Agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Elimination of Drugs:

  • rate of elimination is constant regardless of Cp (ie. constant amount of drug eliminated per unit time)
  • Cp ↓ linearly with time
  • capacity-limited elimination
  • Phenytoin
  • Ethanol
  • Aspirin (at high or toxic concentrations)
A

Zero-Order Elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Elimination of Drugs:

  • rate is directly proportional to the drug concentration (ie. constant fraction of drug eliminated per unit time)
  • Cp ↓ exponentially with time
  • applies to most drugs
  • flow-dependent elimination
A

First-Order Elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Urine pH and Drug Elimination:

trapped in urine and cleared quickly

A

Ionized Species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Urine pH and Drug Elimination: can be reabsorbed
Neutral Forms
26
Urine pH and Drug Elimination: Weak Acids
* Trapped in basic environments. * Treat overdose with _sodium bicarbonate_ to alkalinize urine. * Examples: * Phenobarbital * Methotrexate * Aspirin (Salicylates)
27
Urine pH and Drug Elimination: Weak Bases
* Trapped in acidic environments. * Treat overdose with _ammonium chloride_ to acidify urine. * TCA toxicity is generally treated with sodium bicarbonate to overcome the sodium channelblocking activity of TCAs, but not for accelerating drug elimination. * Examples: * TCAs * Amphetamines
28
Drug Metabolism: * Reduction, Oxidation, Hydrolysis with cytochrome P-450 usually yield slightly polar, water-soluble metabolites (often still active). * Geriatric patients lose this phase first.
Phase I R-OH: * **R**eduction * **O**xidation * **H**ydrolysis
29
Drug Metabolism: * Conjugation (Methylation, Glucuronidation, Acetylation, Sulfation) usually yields very polar, inactive metabolites (renally excreted). * Geriatric patients have more of this phase. * Patients who are slow acetylators have ↑ side effects from certain drugs because of ↓ rate of metabolism.
Phase II Geriatric patients have **M**ore **GAS** (phase II). * **M**ethylation * **G**lucuronidation * **A**cetylation * **S**ulfation
30
\_\_\_\_\_ is the maximal effect a drug can produce.
Efficacy * Represented by the y-value (Vmax). ↑ y-value = ↑ Vmax = ↑ efficacy. * Unrelated to potency (ie. efficacious drugs can have high or low potency). * Partial agonists have less efficacy than full agonists.
31
\_\_\_\_\_ is the amount of drug needed for a given effect.
Potency * Represented by the x-value (EC50). * Left shifting = ↓ EC50 = ↑ potency = ↓ drug needed. * Unrelated to efficacy (ie. potent drugs can have high or low efficacy).
32
\_\_\_\_\_ is the measurement of drug safety.
Therapeutic Index * **TITE**: **T**herapeutic **I**ndex = **T**D50 / **E**D50 * Safer drugs have higher TI values. * Drugs with lower TI values frequently require monitoring (eg. **W**arfarin, **T**heophylline, **D**igoxin, **L**ithium; **W**arning! **T**hese **D**rugs are **L**ethal!). * LD50 (lethal median dose) often replaces TD50 in animal studies.
33
\_\_\_\_\_ is the dosage range that can safely and effectively treat disease.
Therapeutic Window
34
Central and Peripheral Nervous System
* Pelvic splanchnic nerves and CNs III, VII, IX and X are part of the parasympathetic nervous system. * Adrenal medulla is directly innervated by preganglionic sympathetic fibers. * Sweat glands are part of the sympathetic pathway but are innervated by cholinergic fibers.
35
Acetylcholine Receptors: ligand-gated Na+/K+ channels
Nicotinic * NN (found in autonomic ganglia, adrenal medulla) * NM (found in neuromuscular junction of skeletal muscle)
36
Acetylcholine Receptors: G-protein–coupled receptors that usually act through 2nd messengers
Muscarinic * M1–5 found in heart, smooth muscle, brain, exocrine glands, and on sweat glands (cholinergic sympathetic).
37
G-Protein–Linked Second Messengers: * Sympathetic * G-Protein: q * ↑ vascular smooth muscle contraction * ↑ pupillary dilator muscle contraction (mydriasis) * ↑ intestinal and bladder sphincter muscle contraction
α1 “After **qiss**e**s** (kisses), you get a **qiq** (kick) out of **siq** (sick) **sqs** (super qinky sex).”
38
G-Protein–Linked Second Messengers: * Sympathetic * G-Protein: i * ↓ sympathetic (adrenergic) outflow * ↓ insulin release * ↓ lipolysis * ↑ platelet aggregation * ↓ aqueous humor production
α2 “After **qiss**e**s** (kisses), you get a **qiq** (kick) out of **siq** (sick) **sqs** (super qinky sex).”
39
G-Protein–Linked Second Messengers: * Sympathetic * G-Protein: s * ↑ heart rate * ↑ contractility (one heart) * ↑ renin release * ↑ lipolysis
β1 “After **qiss**e**s** (kisses), you get a **qiq** (kick) out of **siq** (sick) **sqs** (super qinky sex).”
40
G-Protein–Linked Second Messengers: * Sympathetic * G-Protein: s * vasodilation * bronchodilation (two lungs) * ↑ lipolysis * ↑ insulin release * ↑ glycogenolysis * ↓ uterine tone (tocolysis) * ↑ aqueous humor production * ↑ cellular K+ uptake
β2 “After **qiss**e**s** (kisses), you get a **qiq** (kick) out of **siq** (sick) **sqs** (super qinky sex).”
41
G-Protein–Linked Second Messengers: * Sympathetic * G-Protein: s * ↑ lipolysis * ↑ thermogenesis in skeletal muscle * ↑ bladder relaxation
β3 “After **qiss**e**s** (kisses), you get a **qiq** (kick) out of **siq** (sick) **sqs** (super qinky sex).”
42
G-Protein–Linked Second Messengers: * Parasympathetic * G-Protein: q * mediates higher cognitive functions * stimulates enteric nervous system
M1 “After **qiss**e**s** (kisses), you get a **qiq** (kick) out of **siq** (sick) **sqs** (super qinky sex).”
43
G-Protein–Linked Second Messengers: * Parasympathetic * G-Protein: i * ↓ heart rate and contractility of atria
M2 “After **qiss**e**s** (kisses), you get a **qiq** (kick) out of **siq** (sick) **sqs** (super qinky sex).”
44
G-Protein–Linked Second Messengers: * Parasympathetic * G-Protein: q * ↑ exocrine gland secretions (eg. lacrimal, sweat, salivary, gastric acid) * ↑ gut peristalsis * ↑ bladder contraction * bronchoconstriction * ↑ pupillary sphincter muscle contraction (miosis) * ciliary muscle contraction (accommodation) * ↑ insulin release
M3 “After **qiss**e**s** (kisses), you get a **qiq** (kick) out of **siq** (sick) **sqs** (super qinky sex).”
45
G-Protein–Linked Second Messengers: * Dopamine * G-Protein: s * relaxes renal vascular smooth muscle * activates direct pathway of striatum
D1 “After **qiss**e**s** (kisses), you get a **qiq** (kick) out of **siq** (sick) **sqs** (super qinky sex).”
46
G-Protein–Linked Second Messengers: * Dopamine * G-Protein: i * modulates transmitter release, especially in brain * inhibits indirect pathway of striatum
D2 “After **qiss**e**s** (kisses), you get a **qiq** (kick) out of **siq** (sick) **sqs** (super qinky sex).”
47
G-Protein–Linked Second Messengers: * Histamine * G-Protein: q * ↑ nasal and bronchial mucus production * ↑ vascular permeability * bronchoconstriction * pruritus * pain
H1 “After **qiss**e**s** (kisses), you get a **qiq** (kick) out of **siq** (sick) **sqs** (super qinky sex).”
48
G-Protein–Linked Second Messengers: * Histamine * G-Protein: s * ↑ gastric acid secretion
H2 “After **qiss**e**s** (kisses), you get a **qiq** (kick) out of **siq** (sick) **sqs** (super qinky sex).”
49
G-Protein–Linked Second Messengers: * Vasopressin * G-Protein: q * ↑ vascular smooth muscle contraction
V1 “After **qiss**e**s** (kisses), you get a **qiq** (kick) out of **siq** (sick) **sqs** (super qinky sex).”
50
G-Protein–Linked Second Messengers: * Vasopressin * G-Protein: s * ↑ H2O permeability and reabsorption via upregulating aquaporin-2 in collecting twobules (tubules) of kidney
V2 “After **qiss**e**s** (kisses), you get a **qiq** (kick) out of **siq** (sick) **sqs** (super qinky sex).”
51
G-Protein–Linked Second Messengers
52
Autonomic Drugs
* Release of norepinephrine from a sympathetic nerve ending is modulated by NE itself, acting on presynaptic α2-autoreceptors → negative feedback. * Amphetamines use the NE transporter (NET) to enter the presynaptic terminal, where they utilize the vesicular monoamine transporter (VMAT) to enter neurosecretory vesicles. This displaces NE from the vesicles. * Once NE reaches a concentration threshold within the presynaptic terminal, the action of NET is reversed, and NE is expelled into the synaptic cleft, contributing to the characteristics and effects of ↑ NE observed in patients taking amphetamines.
53
When using cholinomimetic agents, you should watch out for _____ in susceptible patients.
* exacerbation of COPD * asthma * peptic ulcers
54
Cholinomimetic Agents: * direct agonist * activates bowel and bladder smooth muscle * resistant to AChE * no nicotinic activity * postoperative ileus * neurogenic ileus * urinary retention
Bethanechol “**Bethany**, **call** (**bethanechol**) me to activate your **b**owels and **b**ladder.”
55
Cholinomimetic Agents: * direct agonist * carbon copy of acetylcholine (but resistant to AChE) * constricts pupil * relieves intraocular pressure in open-angle glaucoma
Carbachol **Carbachol** = **car**bon copy of **a**cetyl**chol**ine
56
Cholinomimetic Agents: * direct agonist * stimulates muscarinic receptors in airway when inhaled * challenge test for diagnosis of asthma
Methacholine
57
Cholinomimetic Agents: * direct agonist * contracts ciliary muscle of eye (open-angle glaucoma) and pupillary sphincter (closed-angle glaucoma) * resistant to AChE * can cross blood-brain barrier (tertiary amine) * potent stimulator of sweat, tears, and saliva * xerostomia (Sjögren syndrome)
Pilocarpine “You **cry**, **drool**, and **sweat** on your ‘**pilo**w.’ ”
58
Cholinomimetic Agents: * indirect agonist (anticholinesterase) * ↑ ACh * Alzheimer disease
* Donepezil * Rivastigmine * Galantamine **Dona** & **Riva** dances at the **gala**.
59
Cholinomimetic Agents: * indirect agonist (anticholinesterase) * ↑ ACh * historically used to diagnose myasthenia gravis * replaced by anti-AChR Ab (anti-acetylcholine receptor antibody) test
Edrophonium
60
Cholinomimetic Agents: * indirect agonist (anticholinesterase) * ↑ ACh * postoperative and neurogenic ileus and urinary retention * myasthenia gravis * reversal of neuromuscular junction blockade (postoperative)
Neostigmine **Neo** CNS = **No** CNS penetration (quaternary amine).
61
Cholinomimetic Agents: * indirect agonist (anticholinesterase) * ↑ ACh * antidote for anticholinergic toxicity * atropine overdose
Physostigmine **Ph**reely (freely) crosses blood-brain barrier → CNS (tertiary amine).
62
Cholinomimetic Agents: * indirect agonist (anticholinesterase) * ↑ ACh * ↑ muscle strength * myasthenia gravis (long acting) * does not penetrate CNS (quaternary amine)
Pyridostigmine
63
\_\_\_\_\_ is often due to organophosphates, such as parathion, that irreversibly inhibit AChE. Organophosphates are often components of insecticides; poisoning usually seen in farmers.
Cholinesterase Inhibitor Poisoning
64
Symptoms of Cholinesterase Inhibitor Poisoning
**DUMBBELSS** * **D**iarrhea * **U**rination * **M**iosis * **B**ronchospasm * **B**radycardia * **E**mesis * **L**acrimation * **S**weating * **S**alivation \*may lead to respiratory failure if untreated
65
\_\_\_\_\_ is the antidote for cholinesterase inhibitor poisoning.
Atropine (competitive inhibitor) + Pralidoxime (regenerates AChE if given early)
66
Muscarinic Antagonists: * eye * mydriasis * cycloplegia
* Atropine * Homatropine * Tropicamide
67
Muscarinic Antagonists: * CNS * Parkinson disease * acute dystonia
* Benztropine * Trihexyphenidyl **Park** my **Benz**.
68
Muscarinic Antagonists: * GI * respiratory * Parenteral: preoperative use to reduce airway secretions * Oral: drooling, peptic ulcer
Glycopyrrolate
69
Muscarinic Antagonists: * GI * antispasmodics for irritable bowel syndrome
* Hyoscyamine * Dicyclomine
70
Muscarinic Antagonists: * respiratory * COPD * asthma
* Ipratropium * Tiotropium
71
Muscarinic Antagonists: * genitourinary * reduce bladder spasms * urge urinary incontinence (overactive bladder)
* Oxybutynin * Solifenacin * Tolterodine
72
Muscarinic Antagonists: * CNS * motion sickness
Scopolamine
73
\_\_\_\_\_ is a muscarinic antagonist used to treat bradycardia and for ophthalmic applications. It blocks DUMBBeLSS in cholinesterase inhibitor poisoning. Does not block excitation of skeletal muscle and CNS (mediated by nicotinic receptors).
Atropine
74
Atropine Effects: Eye
* ↑ pupil dilation * cycloplegia
75
Atropine Effects: Airway
* bronchodilation * ↓ secretions
76
Atropine Effects: Stomach
↓ acid secretion
77
Atropine Effects: Gut
↓ motility
78
Atropine Effects: Bladder
↓ urgency in cystitis
79
Adverse Effects of Atropine
* *Hot** as a hare * *Dry** as a bone * *Red** as a beet * *Blind** as a bat * *Mad** as a hatter * *Full** as a flask * ↑ body temperature (due to ↓ sweating) * rapid pulse * dry mouth * dry, flushed skin * cycloplegia * constipation * disorientation * Can cause acute angle-closure glaucoma in elderly (due to mydriasis), urinary retention in men with prostatic hyperplasia, and hyperthermia in infants.
80
\_\_\_\_\_ causes gardener’s pupil (mydriasis due to plant alkaloids).
Jimson weed (*Datura*)
81
Direct Sympathomimetics: * β2 \> β1 * acute asthma * COPD
Albuterol
82
Direct Sympathomimetics: * β2 \> β1 * long-term asthma * COPD
Salmeterol
83
Direct Sympathomimetics: * β2 \> β1 * bronchospasm in asthma * tocolysis
Terbutaline
84
Direct Sympathomimetics: * β1 \> β2, α * heart failure * cardiogenic shock (inotropic \> chronotropic) * cardiac stress testing
Dobutamine
85
Direct Sympathomimetics: * D1 = D2 \> β \> α * unstable bradycardia * heart failure * shock * inotropic and chronotropic effects at lower doses due to β effects * vasoconstriction at high doses due to α effects
Dopamine
86
Direct Sympathomimetics: * β \> α * anaphylaxis * asthma * open-angle glaucoma * α effects predominate at high doses * significantly stronger effect at β2-receptor than norepinephrine
Epinephrine
87
Direct Sympathomimetics: * D1 * postoperative hypertension * hypertensive crisis * vasodilator (coronary, peripheral, renal, and splanchnic) * promotes natriuresis * can cause hypotension and tachycardia
Fenoldopam
88
Direct Sympathomimetics: * β1 = β2 * electrophysiologic evaluation of tachyarrhythmias * can worsen ischemia * has negligible α effect
Isoproterenol
89
Direct Sympathomimetics: * α1 * autonomic insufficiency and postural hypotension * may exacerbate supine hypertension
Midodrine
90
Direct Sympathomimetics: * β3 * urinary urge incontinence or overactive bladder
Mirabegron
91
Direct Sympathomimetics: * α1 \> α2 \> β1 * hypotension * septic shock
Norepinephrine
92
Direct Sympathomimetics: * α1 \> α2 * hypotension (vasoconstrictor) * ocular procedures (mydriatic) * rhinitis (decongestant) * ischemic priapism
Phenylephrine
93
Indirect Sympathomimetics: * indirect general agonist * reuptake inhibitor * releases stored catecholamines
Amphetamine
94
Indirect Sympathomimetics: * indirect general agonist * reuptake inhibitor * causes vasoconstriction and local anesthesia * caution when giving β-blockers if intoxication is suspected (can lead to unopposed α1 activation, activation → extreme hypertension, coronary vasospasm).
Cocaine
95
Indirect Sympathomimetics: * indirect general agonist * releases stored catecholamines * nasal decongestion (pseudoephedrine) * urinary incontinence * hypotension
Ephedrine
96
Norepinephrine vs. Isoproterenol
* NE ↑ systolic and diastolic pressures as a result of α1-mediated vasoconstriction → ↑ mean arterial pressure → reflex bradycardia. * Isoproterenol (rarely used) has little α effect but causes β2-mediated vasodilation, resulting in ↓mean arterial pressure and ↑ heart rate through β1 and reflex activity.
97
Sympatholytics (α2-agonists): * Applications: * hypertensive urgency (limited situations) * ADHD * Tourette syndrome * symptom control in opioid withdrawal * Adverse Effects: * CNS depression * bradycardia * hypotension * respiratory depression * miosis * rebound * hypertension with abrupt cessation
* Clonidine * Guanfacine
98
Sympatholytics (α2-agonists): * Applications: * hypertension in pregnancy * Adverse Effects: * direct Coombs ⊕ hemolysis * drug-induced lupus
α-methyldopa
99
Sympatholytics (α2-agonists): * Applications: * relief of spasticity * Adverse Effects: * hypotension * weakness * xerostomia
Tizanidine
100
α-Blockers: * nonselective * irreversible * Applications: * pheochromocytoma (used preoperatively) to prevent catecholamine (hypertensive) crisis * Adverse Effects: * orthostatic hypotension * reflex tachycardia
Phenoxybenzamine
101
α-Blockers: * nonselective * reversible * Applications: * give to patients on MAO inhibitors who eat tyramine-containing foods and for severe cocaine-induced hypertension (2nd line) * Adverse Effects: * orthostatic hypotension * reflex tachycardia
Phentolamine
102
α-Blockers: * α1 selective * Applications: * urinary symptoms of BPH * PTSD (prazosin) * hypertension (except tamsulosin) * Adverse Effects: * 1st-dose orthostatic hypotension, dizziness, headache
* Prazosin * Terazosin * Doxazosin * Tamsulosin
103
α-Blockers: * α2 selective * Applications: * depression * Adverse Effects: * sedation * ↑ serum cholesterol * ↑ appetite
Mirtazapine
104
Effects of α-Blocker on BP Responses to Epinephrine and Phenylephrine
* Epinephrine response exhibits reversal of mean arterial pressure from a net increase (the α response) to a net decrease (the β2 response). properties). * Phenylephrine response is suppressed but not reversedbecause it is a “pure” α-agonist (lacks β-agonist properties).
105
β-Blockers
* Acebutolol * Atenolol * Betaxolol * Bisoprolol * Carvedilol * Esmolol * Labetalol * Metoprolol * Nadolol * Nebivolol * Pindolol * Propranolol * Timolol
106
β-Blocker Applications: ↓ heart rate and contractility, resulting in ↓ O2 consumption
Angina Pectoris
107
β-Blocker Applications: ↓ production of aqueous humor
Glaucoma * Timolol
108
β-Blocker Applications: ↓ mortality
* Heart Failure * Bisoprolol * Carvedilol * Metoprolol * Myocardial Infarction
109
β-Blocker Applications: * ↓ cardiac output * ↓ renin secretion (due to β1-receptor blockade on JGA cells)
Hypertension
110
β-Blocker Applications: * symptom control (↓ heart rate, ↓ tremor), * thyroid storm
Hyperthyroidism * Propranolol
111
β-Blocker Applications: ↓ heart rate → ↑ filling time, relieving obstruction
Hypertrophic Cardiomyopathy
112
β-Blocker Applications: ↓ AV conduction velocity (class II antiarrhythmic)
Supraventricular Tachycardia * Metoprolol * Esmolol
113
β-Blocker Applications: * ↓ hepatic venous pressure gradient * portal hypertension (prophylactic use)
Variceal Bleeding * Nadolol * Propranolol * Carvedilol
114
Adverse Effects of β-Blockers
* erectile dysfunction * cardiovascular (bradycardia, AV block, HF) * CNS (seizures, sleep alterations) * dyslipidemia (metoprolol) * asthma/COPD exacerbations * use with caution in cocaine users due to risk of unopposed α-adrenergic receptor agonist activity
115
β-Blocker Selectivity: β1-Selective Antagonists (β1 \> β2)
* Acebutolol (partial agonist) * Atenolol * Betaxolol * Bisoprolol * Esmolol * Metoprolol Selective antagonists mostly go from **A** to **M** (β**1** with **1**st half of alphabet)
116
β-Blocker Selectivity: Nonselective Antagonists (β1 = β2)
* Nadolol * Pindolol (partial agonist) * Propranolol * Timolol Nonselective antagonists mostly go from **N** to **Z** (β**2** with **2**nd half of alphabet)
117
β-Blocker Selectivity: Nonselective α- and β-Antagonists
* Carvedilol * Labetalol Nonselective α- and β-antagonists have **modified suffixes** (instead of “-olol”).
118
\_\_\_\_\_ combines cardiac-selective β1‑adrenergic blockade with stimulation of β3‑receptors (activate nitric oxide synthase in the vasculature and ↓ SVR).
Nebivolol **N**ebiv**o**lol increases **NO**.
119
Ingested Seafood Toxins
* **H**istamine (Scombroid poisoning)—**H**istamine release * **T**etrodotoxin—**T**otal block of Na+ channels * **C**iguatoxin—opening of Na+ channels to **C**ause depolarization
120
Ingested Seafood Toxins: * spoiled dark-meat fish such as tuna, mahimahi, mackerel, and bonito * bacterial histidine decarboxylase converts histidine to histamine * frequently misdiagnosed as fish allergy * mimics anaphylaxis: acute burning sensation of mouth, flushing of face, erythema, urticaria, itching * may progress to bronchospasm, angioedema, and hypotension * treated with antihistamines, Albuterol and Epinephrine if needed
Histamine (Scombroid poisoning)
121
Ingested Seafood Toxins: * pufferfish * highly potent toxin * binds fast voltage-gated Na+ channels in cardiac/nerve tissue, preventing depolarization * nausea, diarrhea, paresthesias, weakness, dizziness, loss of reflexes * supportive therapy
Tetrodotoxin
122
Ingested Seafood Toxins: * reef fish such as barracuda, snapper, and moray eel * opens Na+ channels, causing depolarization * nausea, vomiting, diarrhea; perioral numbness * reversal of hot and cold sensations * bradycardia, heart block, hypotension * supportive therapy
Ciguatoxin
123
\_\_\_\_\_ is a widely used criteria developed to reduce potentially inappropriate prescribing and harmful polypharmacy in the geriatric population. Includes \> 50 medications that should be avoided in elderly patients due to ↓ efficacy and/or ↑ risk of adverse events.
Beers Criteria * α-Blockers (↑ risk of hypotension) * Anticholinergics, Antidepressants, Antihistamines, Opioids (↑ risk of delirium, sedation, falls, constipation, urinary retention) * Benzodiazepines (↑ risk of delirium, sedation, falls) * NSAIDs (↑ risk of GI bleeding, especially with concomitant anticoagulation) * PPIs (↑ risk of *C. difficile* infection)
124
Antidotes: Acetaminophen
N-acetylcysteine (replenishes glutathione)
125
Antidotes: * AChE Inhibitors * Organophosphates
Atropine \> Pralidoxime
126
Antidotes: * Antimuscarinic agents * Anticholinergic agents
* Physostigmine * control hyperthermia
127
Antidotes: Arsenic
* Dimercaprol * Succimer
128
Antidotes: Benzodiazepines
Flumazenil
129
Antidotes: β-blockers
* Atropine * Glucagon
130
Antidotes: Carbon Monoxide
* 100% O2 * Hyperbaric O2
131
Antidotes: Copper
* Penicillamine (**copper penny**) * Trientine
132
Antidotes: Cyanide
* Nitrite * Thiosulfate * Hydroxocobalamin
133
Antidotes: Digitalis (Digoxin)
Anti-dig Fab fragments
134
Antidotes: Heparin
Protamine Sulfate
135
Antidotes: Iron
* Deferoxamine * Deferasirox * Deferiprone
136
Antidotes: Lead
* EDTA * Dimercaprol * Succimer * Penicillamine
137
Antidotes: Mercury
* Dimercaprol * Succimer
138
Antidotes: * Methanol * Ethylene Glycol (antifreeze)
* Fomepizole \> Ethanol * Dialysis
139
Antidotes: Methemoglobin
* Methylene Blue * Vitamin C (reducing agent)
140
Antidotes: Opioids
Naloxone
141
Antidotes: Salicylates
* NaHCO3 (alkalinize urine) * dialysis
142
Antidotes: TCAs
NaHCO3 (stabilizes cardiac cell membrane)
143
Antidotes: Warfarin
* Vitamin K (delayed effect) * fresh frozen plasma (immediate)
144
Drug Reactions—Cardiovascular: coronary vasospasm
**CASE** * **C**ocaine * **A**mphetamines * **S**umatriptan * **E**rgot Alkaloids
145
Drug Reactions—Cardiovascular: cutaneous flushing
Flushed from **VANCEN** (dancing): * **V**ancomycin * **A**denosine * **N**iacin * **C**a2+ Channel Blockers * **E**chinocandins * **N**itrates
146
Drug Reactions—Cardiovascular: dilated cardiomyopathy
Anthracyclines * **D**oxorubicin * **D**aunorubicin \*prevented with **D**exrazoxane
147
Drug Reactions—Cardiovascular: torsades de pointes
Prolong QT Interval (**ABCDE**): * anti**A**rrhythmics (class IA, III) * anti**B**iotics (eg. macrolides) * anti“**C**”ychotics (eg. haloperidol) * anti**D**epressants (eg. TCAs) * anti**E**metics (eg. ondansetron)
148
Drug Reactions—Endocrine/Reproductive: adrenocortical insufficiency
HPA suppression 2° to glucocorticoid withdrawal
149
Drug Reactions—Endocrine/Reproductive: diabetes insipidus
* Lithium * Demeclocycline
150
Drug Reactions—Endocrine/Reproductive: hot flashes
SERMs * Tamoxifen * Clomiphene * Raloxifene
151
Drug Reactions—Endocrine/Reproductive: hyperglycemia
**T**he **P**eople **N**eed **H**ard **C**andies: * **T**acrolimus * **P**rotease Inhibitors * **N**iacin * **H**CTZ * **C**orticosteroids
152
Drug Reactions—Endocrine/Reproductive: hyperprolactinemia
* Typical Antipsychotics (eg. haloperidol) * Atypical Antipsychotics (eg. quetiapine) * Metoclopramide * Methyldopa \*presents with hypogonadism (eg. infertility, amenorrhea, erectile dysfunction) and galactorrhea (more common in men)
153
Drug Reactions—Endocrine/Reproductive: hyperthyroidism
* Lithium * Amiodarone
154
Drug Reactions—Endocrine/Reproductive: hypothyroidism
I **AM** **SU**ddenly **L**ethargic: * **AM**iodarone * **SU**lfonamides * **L**ithium
155
Drug Reactions—Endocrine/Reproductive: SIADH
**C**an’t **C**oncentrate **S**erum **S**odium: * **C**arbamazepine * **C**yclophosphamide * **SS**RIs
156
Drug Reactions—Gastrointestinal: * acute cholestatic hepatitis * jaundice
Macrolides (eg. Erythromycin)
157
Drug Reactions—Gastrointestinal: diarrhea
* Acamprosate * Antidiabetic Agents (eg. Acarbose, Metformin, Pramlintide) * Colchicine * Cholinesterase Inhibitors * Lipid-Lowering Agents (eg. Ezetimibe, Orlistat) * Macrolides (eg. Erythromycin) * Quinidine * SSRIs
158
Drug Reactions—Gastrointestinal: focal to massive hepatic necrosis
Liver “**HAVAc**” * **H**alothane * **A**manita phalloides (death cap mushroom) * **V**alproic Acid * **Ac**etaminophen
159
Drug Reactions—Gastrointestinal: hepatitis
* Rifampin * Isoniazid * Pyrazinamide * Statins * Fibrates
160
Drug Reactions—Gastrointestinal: pancreatitis
**D**rugs **C**ausing **A** **V**iolent **A**bdominal **D**istress: * **D**idanosine * **C**orticosteroids * **A**lcohol * **V**alproic Acid * **A**zathioprine * **D**iuretics (Furosemide, HCTZ)
161
Drug Reactions—Gastrointestinal: pill-induced esophagitis
* Bisphosphonates * Ferrous Sulfate * NSAIDs * Potassium Chloride * Tetracyclines \*caustic effect minimized with upright posture and adequate water ingestion
162
Drug Reactions—Gastrointestinal: pseudomembranous colitis
* Ampicillin * Cephalosporins * Clindamycin * Fluoroquinolones \*sntibiotics predispose to superinfection by resistant *C. difficile*
163
Drug Reactions—Hematologic: agranulocytosis
**C**an **C**ause **P**retty **M**ajor **C**ollapse of **G**ranulocytes: * **C**lozapine * **C**arbamazepine * **P**ropylthiouracil * **M**ethimazole * **C**olchicine * **G**anciclovir
164
Drug Reactions—Hematologic: aplastic anemia
**C**an’t **M**ake **N**ew **B**lood **C**ells **P**roperly: * **C**arbamazepine * **M**ethimazole * **N**SAIDs * **B**enzene * **C**hloramphenicol * **P**ropylthiouracil
165
Drug Reactions—Hematologic: direct Coombs positive hemolytic anemia
**P**. **D**iddy **C**oombs: * **P**enicillin * Methyl**D**opa * **C**ephalosporins
166
Drug Reactions—Hematologic: drug reaction with eosinophilia and systemic symptoms (DRESS)
* Allopurinol * Anticonvulsants * Antibiotics * Sulfa Drugs
167
\_\_\_\_\_ is a potentially fatal delayed hypersensitivity reaction. Latency period (2–8 weeks) followed by fever, morbilliform skin rash, and frequent multiorgan involvement. Treatment: withdrawal of offending drug, corticosteroids.
DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms)
168
Drug Reactions—Hematologic: gray baby syndrome
Chloramphenicol
169
Drug Reactions—Hematologic: hemolysis in G6PD deficiency
Hemolysis **IS D PAIN**: * **I**soniazid * **S**ulfonamides * **D**apsone * **P**rimaquine * **A**spirin * **I**buprofen * **N**itrofurantoin
170
Drug Reactions—Hematologic: megaloblastic anemia
You’re **h**aving a **mega** **blast** with **PMS**. * **H**ydroxyurea * **P**henytoin * **M**ethotrexate * **S**ulfa Drugs
171
Drug Reactions—Hematologic: thrombocytopenia
**H**elp! **V**ery **L**ow platelets! * **H**eparin * **V**ancomycin * **L**inezolid
172
Drug Reactions—Hematologic: thrombotic complications
* Combined Oral Contraceptives * Hormone Replacement Therapy * SERMs (eg. Tamoxifen, Raloxifene, Clomiphene) \*estrogen-mediated side effect
173
Drug Reactions—Musculoskeletal/Skin/Connective Tissue: drug-induced lupus
Having lupus is **M**ega “**SHIPP**-**E**” * **M**ethyldopa * **S**ulfa Drugs * **H**ydralazine * **I**soniazid * **P**rocainamide * **P**henytoin * **E**tanercept
174
Drug Reactions—Musculoskeletal/Skin/Connective Tissue: fat redistribution
Fat **PIG**: * **P**rotease **I**nhibitors * **G**lucocorticoids
175
Drug Reactions—Musculoskeletal/Skin/Connective Tissue: gingival hyperplasia
**C**an **C**ause **P**uffy **G**ums * **C**yclosporine * **C**a2+ Channel Blockers * **P**henytoin
176
Drug Reactions—Musculoskeletal/Skin/Connective Tissue: hyperuricemia (gout)
**P**ainful **T**ophi and **F**eet **N**eed **C**are. * **P**yrazinamide * **T**hiazides * **F**urosemide * **N**iacin * **C**yclosporine
177
Drug Reactions—Musculoskeletal/Skin/Connective Tissue: myopathy
* Statins * Fibrates * Niacin * Colchicine * Daptomycin * Hydroxychloroquine * Interferon-α * Penicillamine * Glucocorticoids
178
Drug Reactions—Musculoskeletal/Skin/Connective Tissue: osteoporosis
* Corticosteroids * Depot Medroxyprogesterone Acetate * GnRH Agonists * Aromatase Inhibitors * Anticonvulsants * Heparin * PPIs
179
Drug Reactions—Musculoskeletal/Skin/Connective Tissue: photosensitivity
**SAT** **F**or **photo**: * **S**ulfonamides * **A**miodarone * **T**etracyclines * 5-**F**U
180
Drug Reactions—Musculoskeletal/Skin/Connective Tissue: rash (Stevens-Johnson syndrome)
**Steven Johnson** has **epileptic all**ergy to **sulfa drugs** and **penicillin**. * Anti-**Epileptic** drugs (Lamotrigine) * **All**opurinol * **Sulfa Drugs** * **Penicillin**
181
Drug Reactions—Musculoskeletal/Skin/Connective Tissue: teeth discoloration
Tetracyclines **Teeth**racyclines
182
Drug Reactions—Musculoskeletal/Skin/Connective Tissue: tendon and cartilage damage
Fluoroquinolones
183
Drug Reactions—Neurologic: cinchonism
* Quinidine * Quinine \*can present with tinnitus, hearing/vision loss, psychosis, and cognitive impairment
184
Drug Reactions—Neurologic: Parkinson-like syndrome
cogwheel rigidity of **ARM**: * **A**ntipsychotics * **R**eserpine * **M**etoclopramide
185
Drug Reactions—Neurologic: peripheral neuropathy
* Phenytoin * Vincristine
186
Drug Reactions—Neurologic: pseudotumor cerebri
* Growth Hormones * Tetracyclines * Vitamin A
187
Drug Reactions—Neurologic: seizures
With **seizures**, **I BITE** my tongue. * Isoniazid (vitamin B6 deficiency) * Bupropion * Imipenem/Cilastatin * Tramadol * Enflurane
188
Drug Reactions—Neurologic: tardive dyskinesia
* Antipsychotics * Metoclopramide
189
Drug Reactions—Neurologic: visual disturbance
**T**hese **D**rugs **I**rritate **V**ery **P**recious **E**yes: * **T**opiramate (blurred vision/diplopia, haloes) * **D**igoxin (yellow-tinged vision) * **I**soniazid (optic neuropathy/color vision changes) * **V**igabatrin (bilateral visual field defects) * **P**DE-5 inhibitors (blue-tinged vision) * **E**thambutol (color vision changes)
190
Drug Reactions—Renal/Genitourinary: Fanconi syndrome
* Cisplatin * Ifosfamide * expired Tetracyclines * Tenofovir
191
Drug Reactions—Renal/Genitourinary: hemorrhagic cystitis
* Cyclophosphamide * Ifosfamide \*prevent by coadministering with Mesna
192
Drug Reactions—Renal/Genitourinary: interstitial nephritis
* Penicillins * Furosemide * NSAIDs * Proton Pump Inhibitors * Sulfa Drugs
193
Drug Reactions—Respiratory: dry cough
ACE Inhibitors
194
Drug Reactions—Respiratory: pulmonary fibrosis
**M**y **N**ose **C**annot **B**reathe **B**ad **A**ir. * **M**ethotrexate * **N**itrofurantoin * **C**armustine * **B**leomycin * **B**usulfan * **A**miodarone
195
Drug Reactions—Multiorgan: antimuscarinic
* Atropine * TCAs * H1-Blockers * Antipsychotics
196
Drug Reactions—Multiorgan: Disulfiram-like reaction
**S**orry **P**als, **C**an’t **G**o **M**ingle. * 1st-Generation **S**ulfonylureas * **P**rocarbazine * **C**ephalosporins * **G**riseofulvin * **M**etronidazole
197
Drug Reactions—Multiorgan: nephrotoxicity/ototoxicity
**L**isten **A**nd **P**ee **V**ery **TER**ri**B**ly: * **L**oop Diuretics * **A**minoglycosides * Cis**P**latin * **V**ancomycin * Ampho**TER**icin **B** \*Cisplatin toxicity may respond to amifostine
198
Drugs affecting pupil size: ↑ pupil size (mydriasis)
* Anticholinergics (atropine, TCA, tropicamide, scopolamine, antihistamines) * Drugs of Abuse (amphetamines, cocaine, LSD) * Sympathomimetics
199
Drugs affecting pupil size: ↓ pupil size (miosis)
* Antipsychotics (haloperidol, risperidone, olanzapine) * Drugs of Abuse (eg. heroin/opioids) * Parasympathomimetics (pilocarpine) * Organophosphates
200
Cytochrome P-450 Inducers (+)
**M**ost **chronic alcoholics** **St**eal **Phen**-**Phen** and **Nev**er **Ref**use **Greas**y **Carb**s. * **M**odafinil * **Chronic Alcohol U**se * **St**. John’s Wort * **Phen**ytoin * **Phen**obarbital * **Nev**irapine * **Rif**ampin * **Gris**eofulvin * **Carb**amazepine
201
Cytochrome P-450 Substrates
**A**lways **T**hink **W**hen **O**utdoors: * **A**nti-Epileptics * **T**heophylline * **W**arfarin * **O**CPs
202
Cytochrome P-450 Inhibitors (–)
**SICKFACES**.**COM** (when I **A**m drinking **grapefruit juice**): * **S**odium Valproate * **I**soniazid * **C**imetidine * **K**etoconazole * **F**luconazole * **A**cute Alcohol Abuse * **C**hloramphenicol * **E**rythromycin/Clarithromycin * **S**ulfonamides * **C**iprofloxacin * **O**meprazole * **M**etronidazole * **Am**iodarone * **Grapefruit Juice**
203
Sulfa Drugs
**S**cary **S**ulfa **P**harm **FACTS**: * **S**ulfonamide Antibiotics * **S**ulfasalazine * **P**robenecid * **F**urosemide * **A**cetazolamide * **C**elecoxib * **T**hiazides * **S**ulfonylureas
204
Patients with sulfa allergies may develop \_\_\_\_\_. Symptoms range from mild to life threatening.
* fever * urinary tract infection * Stevens-Johnson syndrome * hemolytic anemia * thrombocytopenia * agranulocytosis * acute interstitial nephritis * urticaria (hives)
205
Antimicrobials: ergosterol synthesis inhibitor
-azole Ketocon**azole**
206
Antimicrobials: antiparasitic/antihelminthic
-bendazole Me**bendazole**
207
Antimicrobials: transpeptidase (penicillin-binding protein)
-cillin Ampi**cillin**
208
Antimicrobials: protein synthesis inhibitor
-cycline Tetra**cycline**
209
Antimicrobials: neuraminidase inhibitor
-ivir Oseltam**ivir**
210
Antimicrobials: protease inhibitor
-navir Rito**navir**
211
Antimicrobials: DNA polymerase inhibitor
-ovir Acycl**ovir**
212
Antimicrobials: macrolide antibiotic
-thromycin Azit**hromycin**
213
CNS Drugs: inhalational general anesthetic
-ane Haloth**ane**
214
CNS Drugs: typical antipsychotic
-azine Thiorid**azine**
215
CNS Drugs: barbiturate
-barbital Pheno**barbital**
216
CNS Drugs: local anesthetic
-caine Lido**caine**
217
CNS Drugs: TCA
* -ipramine * -triptyline Im**ipramine** Ami**triptyline**
218
CNS Drugs: 5-HT1B/1D Agonist
-triptan Suma**triptan**
219
CNS Drugs: benzodiazepine
* -zepam * -zolam Dia**zepam** Alpra**zolam**
220
Autonomic Drugs: cholinergic agonist
-chol Bethane**chol** Carba**chol**
221
Autonomic Drugs: nondepolarizing paralytics
* -curium * -curonium Atra**curium** Ve**curonium**
222
Autonomic Drugs: β-blocker
-olol Propran**olol**
223
Autonomic Drugs: AChE inhibitor
-stigmine Neo**stigmine**
224
Autonomic Drugs: β2-agonist
-terol Albu**terol**
225
Autonomic Drugs: α1-antagonist
-zosin Pra**zosin**
226
Cardiovascular Drugs: PDE-5 inhibitor
-afil Silden**afil**
227
Cardiovascular Drugs: dihydropyridine Ca2+ channel blocker
-dipine Amlo**dipine**
228
Cardiovascular Drugs: ACE inhibitor
-pril Capto**pril**
229
Cardiovascular Drugs: angiotensin-II receptor blocker
-sartan Lo**sartan**
230
Cardiovascular Drugs: direct factor Xa inhibitor
-xaban Api**xaban** Edo**xaban** Rivaro**xaban**
231
Drugs: bisphosphonate
-dronate Alen**dronate**
232
Drugs: DPP-4 inhibitors
-gliptin Sita**gliptin**
233
Drugs: PPAR-γ activator
-glitazone Rosi**glitazone**
234
Drugs: calcineurin inhibitor
-limus Evero**limus** Tacro**limus**
235
Drugs: proton pump inhibitor
-prazole Ome**prazole**
236
Drugs: prostaglandin analog
-prost Latano**prost**
237
Drugs: endothelin receptor antagonist
-sentan Bo**sentan**
238
Drugs: H2-antagonist
-tidine Cime**tidine**
239
Drugs: pituitary hormone
-tropin Somato**tropin**
240
Monoclonal Antibodies: chimeric human-mouse monoclonal Ab
-ximab Ritu**ximab**
241
Monoclonal Antibodies: humanized mouse monoclonal Ab
-zumab Bevaci**zumab**
242
Monoclonal Antibodies: human monoclonal Ab
-mumab Ipili**mumab**
243
Small Molecule Inhibitors: tyrosine kinase inhibitor
-tinib Ima**tinib**
244
Small Molecule Inhibitors: proteasome inhibitor
-zomib Borte**zomib**
245
Small Molecule Inhibitors: cyclin-dependent kinase inhibitor
-ciclib Palbo**ciclib**
246
Receptor Fusion Proteins: TNF-α antagonist
-cept Etaner**cept**
247
Interleukin Receptor Modulators: IL-2 agonist/analog
-leukin Aldes**leukin**
248
Interleukin Receptor Modulators: interleukin receptor antagonist
-kinra Ana**kinra**